Dr. Henry Miller and John Batchelor Review FDA COVID-19 Guidelines

PRI’s Dr. Henry Miller joins the John Batchelor Show to review the latest developments with the vaccine guidelines and the FDA. The FDA testified before Congress that they will have complicated guidelines for a potential COVID-19 vaccine. Miller mentioned that the FDA guidelines are reassuring as it indicates that future vaccines will be vetted like any other vaccine evaluation (pre-critical data, manufacturing and controls, and clinical data).

The FDA does have an elevated approval process for a drug that treats a life-threatening disease, but Miller explains that any potential coronavirus vaccine won’t be eligible for this process. Miller and Batchelor also discuss a study about COVID-19 antibodies from Germany and it’s impact on vaccine development.

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top